Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist-mediated activation mechanism

  1. James P Bridges
  2. Caterina Safina
  3. Bernard Pirard
  4. Kari Brown
  5. Alyssa Filuta
  6. Ravichandran Panchanathan
  7. Rochdi Bouhelal
  8. Nicole Reymann
  9. Sejal Patel
  10. Klaus Seuwen
  11. William E Miller
  12. Marie-Gabrielle Ludwig  Is a corresponding author
  1. Cincinnati Children's Hospital Medical Center, United States
  2. Novartis, Switzerland
  3. University of Cincinnati, United States
  4. Novartis, United States

Abstract

The mechanistic details of the tethered agonist mode of activation for the adhesion GPCR ADGRF5/GPR116 has not been completely deciphered. We set out to investigate the physiologic importance of autocatalytic cleavage upstream of the agonistic peptide sequence, an event necessary for NTF displacement and subsequent receptor activation. To examine this hypothesis, we characterized tethered agonist-mediated activation of GPR116 in vitro and in vivo. A knock-in mouse expressing a non-cleavable GPR116 mutant phenocopies the pulmonary phenotype of GPR116 knock-out mice, demonstrating that tethered agonist-mediated receptor activation is indispensable for function in vivo. Using site-directed mutagenesis and species swapping approaches we identified key conserved amino acids for GPR116 activation in the tethered agonist sequence and in extracellular loops 2/3 (ECL2/3). We further highlight residues in transmembrane7 (TM7) that mediate stronger signaling in mouse versus human GPR116 and recapitulate these findings in a model supporting tethered agonist:ECL2 interactions for GPR116 activation.

Data availability

Source data for the modeling is provided (coordinates of the model)

Article and author information

Author details

  1. James P Bridges

    Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States
    Competing interests
    No competing interests declared.
  2. Caterina Safina

    Novartis Institutes for Biomedical Research, Novartis, Basel, Switzerland
    Competing interests
    Caterina Safina, is employed by and shareholder of Novartis Pharma AG..
  3. Bernard Pirard

    Novartis Institutes for Biomedical Research, Novartis, Basel, Switzerland
    Competing interests
    Bernard Pirard, is employed by and shareholder of Novartis Pharma AG..
  4. Kari Brown

    Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States
    Competing interests
    No competing interests declared.
  5. Alyssa Filuta

    Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States
    Competing interests
    No competing interests declared.
  6. Ravichandran Panchanathan

    Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, Cincinnati, United States
    Competing interests
    No competing interests declared.
  7. Rochdi Bouhelal

    Novartis Institutes for Biomedical Research, Novartis, Basel, Switzerland
    Competing interests
    Rochdi Bouhelal, is employed by and shareholder of Novartis Pharma AG..
  8. Nicole Reymann

    Novartis Institutes for Biomedical Research, Novartis, Basel, Switzerland
    Competing interests
    Nicole Reymann, is employed by and shareholders of Novartis Pharma AG.
  9. Sejal Patel

    Novartis Institutes for Biomedical Research, Novartis, Cambridge, United States
    Competing interests
    Sejal Patel, is employed by and shareholder of Novartis Pharma AG..
  10. Klaus Seuwen

    Novartis Institutes for Biomedical Research, Novartis, Basel, Switzerland
    Competing interests
    Klaus Seuwen, is employed by and shareholder of Novartis Pharma AG..
  11. William E Miller

    Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, Cincinnati, United States
    Competing interests
    No competing interests declared.
  12. Marie-Gabrielle Ludwig

    Novartis Institutes for Biomedical Research, Novartis, Basel, Switzerland
    For correspondence
    marie-gabrielle.ludwig@novartis.com
    Competing interests
    Marie-Gabrielle Ludwig, is employed by and shareholder of Novartis Pharma AG..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7799-4782

Funding

National Heart, Lung and Blood Institute of the NIH (HL131634)

  • Caterina Safina
  • Bernard Pirard

This work was funded in part by the NIH grant listed above.

Ethics

Animal experimentation: All animal procedures were performed under protocols (AS2842_05_22; JPB) approved by the Institutional Animal Care and Use Committee of National Jewish Health in accordance with National Institutes of Health guidelines.

Copyright

© 2022, Bridges et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,205
    views
  • 269
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. James P Bridges
  2. Caterina Safina
  3. Bernard Pirard
  4. Kari Brown
  5. Alyssa Filuta
  6. Ravichandran Panchanathan
  7. Rochdi Bouhelal
  8. Nicole Reymann
  9. Sejal Patel
  10. Klaus Seuwen
  11. William E Miller
  12. Marie-Gabrielle Ludwig
(2022)
Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist-mediated activation mechanism
eLife 11:e69061.
https://doi.org/10.7554/eLife.69061

Share this article

https://doi.org/10.7554/eLife.69061

Further reading

    1. Cell Biology
    Tomoharu Kanie, Roy Ng ... Peter K Jackson
    Research Article

    The primary cilium is a microtubule-based organelle that cycles through assembly and disassembly. In many cell types, formation of the cilium is initiated by recruitment of ciliary vesicles to the distal appendage of the mother centriole. However, the distal appendage mechanism that directly captures ciliary vesicles is yet to be identified. In an accompanying paper, we show that the distal appendage protein, CEP89, is important for the ciliary vesicle recruitment, but not for other steps of cilium formation (Tomoharu Kanie, Love, Fisher, Gustavsson, & Jackson, 2023). The lack of a membrane binding motif in CEP89 suggests that it may indirectly recruit ciliary vesicles via another binding partner. Here, we identify Neuronal Calcium Sensor-1 (NCS1) as a stoichiometric interactor of CEP89. NCS1 localizes to the position between CEP89 and a ciliary vesicle marker, RAB34, at the distal appendage. This localization was completely abolished in CEP89 knockouts, suggesting that CEP89 recruits NCS1 to the distal appendage. Similarly to CEP89 knockouts, ciliary vesicle recruitment as well as subsequent cilium formation was perturbed in NCS1 knockout cells. The ability of NCS1 to recruit the ciliary vesicle is dependent on its myristoylation motif and NCS1 knockout cells expressing a myristoylation defective mutant failed to rescue the vesicle recruitment defect despite localizing properly to the centriole. In sum, our analysis reveals the first known mechanism for how the distal appendage recruits the ciliary vesicles.

    1. Cell Biology
    Tomoharu Kanie, Beibei Liu ... Peter K Jackson
    Research Article

    Distal appendages are nine-fold symmetric blade-like structures attached to the distal end of the mother centriole. These structures are critical for formation of the primary cilium, by regulating at least four critical steps: ciliary vesicle recruitment, recruitment and initiation of intraflagellar transport (IFT), and removal of CP110. While specific proteins that localize to the distal appendages have been identified, how exactly each protein functions to achieve the multiple roles of the distal appendages is poorly understood. Here we comprehensively analyze known and newly discovered distal appendage proteins (CEP83, SCLT1, CEP164, TTBK2, FBF1, CEP89, KIZ, ANKRD26, PIDD1, LRRC45, NCS1, CEP15) for their precise localization, order of recruitment, and their roles in each step of cilia formation. Using CRISPR-Cas9 knockouts, we show that the order of the recruitment of the distal appendage proteins is highly interconnected and a more complex hierarchy. Our analysis highlights two protein modules, CEP83-SCLT1 and CEP164-TTBK2, as critical for structural assembly of distal appendages. Functional assays revealed that CEP89 selectively functions in RAB34+ ciliary vesicle recruitment, while deletion of the integral components, CEP83-SCLT1-CEP164-TTBK2, severely compromised all four steps of cilium formation. Collectively, our analyses provide a more comprehensive view of the organization and the function of the distal appendage, paving the way for molecular understanding of ciliary assembly.